Skip to content
HowShorted

Korro Bio, Inc. short interest in 2021

In 2021, Korro Bio, Inc.'s disclosed short interest ran from 12.40% of shares outstanding on 15 Jan 2021 to 10.36% on 31 Dec 2021, a change of -2.04 percentage points. The year's high was 23.28% on 31 Mar 2021 and its low 10.36% on 31 Dec 2021, averaging 14.70% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.57 days on 15 Sep 2021. Full history: Korro Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Korro Bio, Inc. in 2021

2021 in figures

Start of year
12.40% (15 Jan 2021)
End of year
10.36% (31 Dec 2021)
Change
-2.04 pp
High
23.28% (31 Mar 2021)
Low
10.36% (31 Dec 2021)
Average
14.70%
Highest days to cover
37.57 (15 Sep 2021)
SEC filings marked
10

Every report in 2021

Korro Bio, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202112.40%21.21
29 Jan 202112.12%17.04
12 Feb 202111.65%15.38
26 Feb 202115.76%20.91
15 Mar 202112.34%11.91
31 Mar 202123.28%2.05results (8-K), 10-K filed, results (8-K)
15 Apr 202117.80%2.55
30 Apr 202114.95%7.43
14 May 202115.93%9.3310-Q filed, results (8-K)
28 May 202117.86%12.16
15 Jun 202117.49%18.45
30 Jun 202116.00%7.32
15 Jul 202116.72%17.58
30 Jul 202116.59%27.92
13 Aug 202115.57%28.6610-Q filed, results (8-K)
31 Aug 202114.64%24.86
15 Sep 202114.84%37.57
30 Sep 202113.47%17.05
15 Oct 202113.33%35.96
29 Oct 202112.58%33.66
15 Nov 202113.29%23.39results (8-K), 10-Q filed, results (8-K)
30 Nov 202112.43%20.57
15 Dec 202111.47%15.82
31 Dec 202110.36%16.92

See also: Korro Bio, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.